Skip to main content
. 2018 Jul 13;9(54):30355–30362. doi: 10.18632/oncotarget.25735

Table 3. Multivariate analysis.

Multivariate p HR (95% CI)
Age < 50 years 0.823 1.1 (0.4–2.8)
Positive surgical margins 0.2 2.163 (0.6–7.1)
Positive lymphovascular permeations 0.213 2.171 (0.6–7.3)
Stage I vs.
Stage II 0.923 1.06 (0.3–4)
Stage III 0.099 3.246 (0.8–13.1)
Stage IV 0.152 5.45 (0.5–55–5)
Luminal A 0.193 0.482 (0.2–1.4)
No adjuvant RT 0.001 6.588 (2.1–19.9)